Translations:Angiotensin II receptor blocker/46/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 18:03, 25 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Angiotensin II receptor blocker)
== External links ==
* {{MeshName|Angiotensin II Type 1 Receptor Blockers}}
* {{cite web | title=Nitrosamine impurities in medications: Guidance | website=Health Canada | date=4 April 2022 | url=https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/nitrosamine-impurities/medications-guidance.html }}

External links

  • Angiotensin II Type 1 Receptor Blockers at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
  • "Nitrosamine impurities in medications: Guidance". Health Canada. 4 April 2022.
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Angiotensin_II_receptor_blocker/46/en&oldid=131278"